Dose-dependent effects on engraftment success
| Cells injected per recipient, C . | Recipients, N(C) . | Survivors, S(C) . | Engraftment successes, G(C) . | ||
|---|---|---|---|---|---|
| No. . | % of recipients . | No. . | % of recipients . | ||
| 100 000 | 86 | 25 | 29.1 | 25 | 29.0 |
| 75 000 | 48 | 22 | 45.8 | 16 | 33.3 |
| 50 000 | 95 | 48 | 50.5 | 36 | 37.8 |
| 25 000 | 46 | 11 | 23.9 | 7 | 15.2 |
| 15 000 | 40 | 17 | 42.5 | 10 | 25.0 |
| 10 000 | 82 | 24 | 29.3 | 16 | 19.5 |
| 5000 | 46 | 15 | 32.6 | 6 | 13.0 |
| 1000 | 45 | 6 | 13.3 | 1 | 2.2 |
| 500 | 37 | 3 | 8.1 | 1 | 2.7 |
| 100 | 48 | 4 | 8.3 | 1 | 2.1 |
| Cells injected per recipient, C . | Recipients, N(C) . | Survivors, S(C) . | Engraftment successes, G(C) . | ||
|---|---|---|---|---|---|
| No. . | % of recipients . | No. . | % of recipients . | ||
| 100 000 | 86 | 25 | 29.1 | 25 | 29.0 |
| 75 000 | 48 | 22 | 45.8 | 16 | 33.3 |
| 50 000 | 95 | 48 | 50.5 | 36 | 37.8 |
| 25 000 | 46 | 11 | 23.9 | 7 | 15.2 |
| 15 000 | 40 | 17 | 42.5 | 10 | 25.0 |
| 10 000 | 82 | 24 | 29.3 | 16 | 19.5 |
| 5000 | 46 | 15 | 32.6 | 6 | 13.0 |
| 1000 | 45 | 6 | 13.3 | 1 | 2.2 |
| 500 | 37 | 3 | 8.1 | 1 | 2.7 |
| 100 | 48 | 4 | 8.3 | 1 | 2.1 |
These are the raw data used to calculate the limiting dilution assay graphed in Figure 2.